Branch Retinal Vein Occlusion: Treatment Modalities: An Update of the Literature

References

• Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: The Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000;98:133–141
   PubMedGoogle Scholar
• Rehak J, Rehak M. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 2008;33:111–131
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994;117:429–441
   PubMed Web of Science ®Google Scholar
• Parodi MB, Bandello F. Branch retinal vein occlusion: Classification and treatment. Ophthalmologica 2009;223(5):298–305
   Google Scholar
• Squizzato A, Manfredi E, Bozzato S, et al. Antithrombotic and fibrinolytic drugs for retinal vein occlusion: A systematic review and a call for action. Thromb Haemost 2010;103:271–276
   Google Scholar
• Houtsmuller AJ, Vermeulen JA, Klompe M, et al. The influence of ticlopidine on the natural course of retinal vein occlusion. Agents Actions Suppl 1984;15:219–229
   PubMedGoogle Scholar
• Glacet-Bernard A, Coscas G, Chabanel A, et al. A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin. Am J Ophthalmol 1994;118:421–429
   PubMed Web of Science ®Google Scholar
• Kreutzer A, Brunner R, Schäfer HJ, et al. Thrombolytic therapy with recombinant tissue-type plasminogen activator in patients with branch or central vein occlusion of the retina. Fortschr Ophthalmol 1988;85:511–513
   PubMedGoogle Scholar
• Steinkamp GW, Hattenbach LO, Scharrer I, Ohrloff C. Front-loading RT PA thrombolytic therapy in central or venous branch occlusions of the retina. Ophthalmologe 1994;91:280–282
   Google Scholar
• Weiss JN. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Am J Ophthalmol 1998;126:142–144
   PubMed Web of Science ®Google Scholar
• Hattenbach LO, Steinkamp G, Scharrer I, Ohrloff C. Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion. Ophthalmologica 1998;212:394–398
   Google Scholar
• Hattenbach LO, Friedrich Arndt C, Lerche R, et al. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): A prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion. Retina 2009;29:932–940
   PubMed Web of Science ®Google Scholar
• Murakami T, Takagi H, Kita M, et al. Intravitreal tissue plasminogen activator to treat macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2006;142:318–320
   PubMed Web of Science ®Google Scholar
• Kumagai K, Ogino N, Furukawa M, Larson E. Three treatments for macular edema because of branch retinal vein occlusion: Intravitreous bevacizumab or tissue plasminogen activator, and vitrectomy. Retina 2012;32:520–529
   Google Scholar
• Tagami M, Kusuhara S, Imai H, et al. Impact of intravitreal injection of tissue plasminogen activator on full-field electroretinogram in patients with macular oedema secondary to retinal vein occlusion. Ophthalmologica 2011;226:81–86
   Google Scholar
• Lazo-Langner A, Hawel J, Ageno W, Kovacs MJ. Low molecular weight heparin for the treatment of retinal vein occlusion: A systematic review and meta-analysis of randomized trials. Haematologica 2010;95:1587–1593
   PubMed Web of Science ®Google Scholar
• Steigerwalt RD Jr, Cesarone MR, Belcaro G, et al. Retinal and orbital venous occlusions treated with enoxaparin. J Ocul Pharmacol Ther 2008;24:421–426
   PubMed Web of Science ®Google Scholar
• Farahvash MS, Moradimogadam M, Farahvash MM, et al. Dalteparin versus aspirin in recent-onset branch retinal vein occlusion: A randomized clinical trial. Arch Iran Med 2008;11:418–422
   Google Scholar
• Ageno W, Cattaneo R, Manfredi E, et al. Parnaparin versus aspirin in the treatment of retinal vein occlusion: A randomized, double blind, controlled study. Thromb Res 2010;125:137–141
   Google Scholar
• McIntosh RL, Mohamed Q, Saw SM, Wong TY. Interventions for branch retinal vein occlusion: An evidence-based systematic review. Ophthalmology 2007;114:835–854
   PubMed Web of Science ®Google Scholar
• Poupard P, Eledjam JJ, Dupeyron G, et al. Role of acute normovolemic hemodilution in treating retinal venous occlusions. Ann Fr Anesth Reanim 1986;5:229–233
   PubMedGoogle Scholar
• Hansen LL, Wiek J, Arntz R. Randomized study of the effect of isovolemic hemodilution in retinal branch vein occlusion. Fortschr Ophthalmol 1988;85:514–516
   PubMedGoogle Scholar
• Chen HC, Wiek J, Gupta A, et al. Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion. Br J Ophthalmol 1998;82:162–167
   PubMed Web of Science ®Google Scholar
• Osterloh MD, Charles S. Surgical decompression of branch retinal vein occlusions. Arch Ophthalmol 1988;106:1469–1471
   PubMedGoogle Scholar
• Opremcak EM, Bruce RA. Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: A prospective review of 15 cases. Retina 1999;19:1–5
   PubMed Web of Science ®Google Scholar
• Shah GK, Sharma S, Fineman MS, et al. Arteriovenous adventitial sheathotomy for the treatment of macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2000;129:104–106
   Web of Science ®Google Scholar
• Le Rouic JF, Bejjani RA, Rumen F, et al. Adventitial sheathotomy for decompression of recent onset branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2001;239:747–751
   Google Scholar
• Dotrelova D, Dubska Z, Kuthan P, Stepankova J. Initial experience with surgical decompression of the vein in branch retinal vein occlusion. Cesk Slov Oftalmol 2001;57:359–366
   Google Scholar
• Mester U, Dillinger P. Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina 2002;22:740–746
   PubMed Web of Science ®Google Scholar
• Cahill MT, Kaiser PK, Sears JE, Fekrat S. The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 2003;87:1329–1332
   Google Scholar
• Becquet F, Le Rouic JF, Zanlonghi X, et al. Efficiency of surgical treatment for chronic macular edema due to branch retinal vein occlusion. J Fr Ophtalmol 2003;26:570–576
   Google Scholar
• Martínez-Soroa I, Ruiz Miguel M, Ostolaza JI, et al. Surgical arteriovenous decompression (sheathotomy) in branch retinal vein occlusion: Retrospective study. Arch Soc Esp Oftalmol 2003;78:603–608
   Google Scholar
• Han DP, Bennett SR, Williams DF, Dev S. Arteriovenous crossing dissection without separation of the retina vessels for treatment of branch retinal vein occlusion. Retina 2003;23:145–151
   PubMed Web of Science ®Google Scholar
• Lu L, Li Y, Yi C, et al. Preliminary clinical observation of arteriovenous sheathotomy for treatment of branch retinal vein occlusion. Yan Ke Xue Bao 2003;19:33–38
   Google Scholar
• Fujii GY, de Juan E Jr, Humayun MS. Improvements after sheathotomy for branch retinal vein occlusion documented by optical coherence tomography and scanning laser ophthalmoscope. Ophthalmic Surg Lasers Imaging 2003;34:49–52
   Google Scholar
• Mason J 3rd, Feist R, White M Jr, et al. Sheathotomy to decompress branch retinal vein occlusion: A matched control study. Ophthalmology 2004;111:540–545
   PubMed Web of Science ®Google Scholar
• Lerche RC, Richard G. Arteriovenous sheathotomy in venous thrombosis. Klin Monatsbl Augenheilkd 2004;221:479–484
   Google Scholar
• Asensio Sánchez VM, Rodríguez Bravo I, Botella Oltra G. Adventitial sheathotomy in branch retinal vein occlusion with non ischemic macular edema. Arch Soc Esp Oftalmol 2004;79:347–352
   Google Scholar
• Charbonnel J, Glacet-Bernard A, Korobelnik JF, et al. Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol 2004;242:223–228
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Saito W, Yagi F, et al. Vitrectomy with or without arteriovenous adventitial sheathotomy for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2004;138:907–914
   PubMed Web of Science ®Google Scholar
• García-Arumí J, Martinez-Castillo V, Boixadera A, et al. Management of macular edema in branch retinal vein occlusion with sheathotomy and recombinant tissue plasminogen activator. Retina 2004;24:530–540
   PubMed Web of Science ®Google Scholar
• Fujimoto R, Ogino N, Kumagai K, et al. The efficacy of arteriovenous adventitial sheathotomy for macular edema in branch retinal vein occlusion. Nihon Ganka Gakkai Zasshi 2004;108:144–149
   Google Scholar
• Lakhanpal RR, Javaheri M, Ruiz-Garcia H, et al. Transvitreal limited arteriovenous-crossing manipulation without vitrectomy for complicated branch retinal vein occlusion using 25-gauge instrumentation. Retina 2005;25:272–280
   Google Scholar
• Horio N, Horiguchi M. Effect of arteriovenous sheathotomy on retinal blood flow and macular edema in patients with branch retinal vein occlusion. Am J Ophthalmol 2005;139:739–740
   PubMed Web of Science ®Google Scholar
• Wrigstad A, Algvere P. Arteriovenous adventitial sheathotomy for branch retinal vein occlusion: Report of a case with longterm follow-up. Acta Ophthalmol Scand 2006;84:699–702
   Google Scholar
• Feltgen N, Herrmann J, Agostini H, et al. Arterio-venous dissection after isovolaemic haemodilution in branch retinal vein occlusion: A non-randomised prospective study. Graefes Arch Clin Exp Ophthalmol 2006;244:829–835
   Google Scholar
• Sohn JH, Song SJ. Arteriovenous sheathotomy for persistent macular edema in branch retinal vein occlusion. Korean J Ophthalmol 2006;20:210–214
   Google Scholar
• Avci R, Inan UU, Kaderli B. Evaluation of arteriovenous crossing sheathotomy for decompression of branch retinal vein occlusion. Eye 2008;22:120–127
   PubMed Web of Science ®Google Scholar
• Kumagai K, Furukawa M, Ogino N, et al. Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina 2007;27:49–54
   PubMed Web of Science ®Google Scholar
• Crafoord S, Karlsson N, la Cour M. Sheathotomy in complicated cases of branch retinal vein occlusion. Acta Ophthalmol 2008;86:146–150
   Google Scholar
• Chung EJ, Freeman WR, Koh HJ. Visual acuity and multifocal electroretinographic changes after arteriovenous crossing sheathotomy for macular edema associated with branch retinal vein occlusion. Retina 2008;28:220–225
   PubMed Web of Science ®Google Scholar
• Oh IK, Kim S, Oh J, Huh K. Long-term visual outcome of arteriovenous adventitial sheathotomy on branch retinal vein occlusion induced macular edema. Korean J Ophthalmol 2008;22:1–5
   PubMedGoogle Scholar
• Chung EJ, Lee H, Koh HJ. Arteriovenous crossing sheathotomy versus intravitreal triamcinolone acetonide injection for treatment of macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2008;246:967–974
   PubMed Web of Science ®Google Scholar
• Shimura M, Nakazawa T, Yasuda K, et al. Visual prognosis and vitreous cytokine levels after arteriovenous sheathotomy in branch retinal vein occlusion associated with macular oedema. Acta Ophthalmol 2008;86:377–384
   Google Scholar
• Stoffelns BM, Kramann C, Schoepfer K. Arteriovenous crossing sheathotomy in branch retinal vein occlusion. Klin Monbl Augenheilkd 2009;226:310–314
   Google Scholar
• Hwang JC, Gelman SK, Fine HF, et al. Combined arteriovenous sheathotomy and intraoperative intravitreal triamcinolone acetonide for branch retinal vein occlusion. Br J Ophthalmol 2010;94:1483–1489
   PubMed Web of Science ®Google Scholar
• Muqit MM, Saidkasimova S, Keating D, Murdoch JR. Long-term study of vascular perfusion effects following arteriovenous sheathotomy for branch retinal vein occlusion. Acta Ophthalmol 2010;88:e57–65
   Google Scholar
• Skevas C, Wagenfeld L, Feucht M, et al. Functional and morphological long-term results after arteriovenous crossing sheathotomy. Acta Ophthalmol 2011;89:e374–375
   Google Scholar
• Amirikia A, Scott IU, Murray TG, et al. Outcomes of vitreoretinal surgery for complications of branch retinal vein occlusion. Ophthalmology 2001;108:372–376
   Google Scholar
• Noma H, Funatsu H, Mimura T, et al. Visual acuity and foveal thickness after vitrectomy for macular edema associated with branch retinal vein occlusion: A case series. BMC Ophthalmol 2010;10:11
   PubMed Web of Science ®Google Scholar
• Taki W, Oohira A, Hirakata A. Macular edema from distant branch retinal vein occlusion improved after vitrectomy. Jpn J Ophthalmol 2009;53:184–186
   Google Scholar
• Yamasaki M, Noma H, Funatsu H, et al. Changes in foveal thickness after vitrectomy for macular edema with branch retinal vein occlusion and intravitreal vascular endothelial growth factor. Int Ophthalmol 2009;29:161–167
   Google Scholar
• Kumagai K, Furukawa M, Ogino N, et al. Long-term visual outcomes after vitrectomy for macular edema with foveal hemorrhage in branch retinal vein occlusion. Retina 2007;27:584–588
   Google Scholar
• Harino S, Bessho K, Kida T. Prospective multicenter study of visual outcomes following three different treatments for macular edema associated with branch retinal vein occlusion: A study by the Japanese BRVO study group. Jpn J Ophthalmol 2012;56:250–261
   Google Scholar
• Sato T, Sawada K, Iwahashi-Shima C, et al. 25-gauge vitrectomy versus intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion: 1 year follow-up. Ann Acad Med Singapore 2012;41:294–299
   Google Scholar
• Noma H, Shimada K, Mimura T. Visual function after pars plana vitrectomy in macular edema with branch retinal vein occlusion. Int Ophthalmol 2013;33:227--236
   Google Scholar
• Stefánsson E, Novack RL, Hatchell DL. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 1990;31:284–289
   PubMed Web of Science ®Google Scholar
• Baharivand N, Hariri A, Javadzadeh A, et al. Pars plana vitrectomy and internal limiting membrane peeling for macular edema secondary to retinal vein occlusion. Clin Ophthalmol 2011;5:1089–1093
   Google Scholar
• Raszewska-Steglinska M, Gozdek P, Cisiecki S, et al. Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol 2009;19:1055–1062
   Google Scholar
• Arai M, Yamamoto S, Mitamura Y, et al. Efficacy of vitrectomy and internal limiting membrane removal for macular edema associated with branch retinal vein occlusion. Ophthalmologica 2009;223:172–176
   Google Scholar
• Mandelcorn MS, Nrusimhadevara RK. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: A report of 14 cases. Retina 2004;24:348–355
   PubMed Web of Science ®Google Scholar
• Ma J, Yao K, Zhang Z, Tang X. 25-gauge vitrectomy and triamcinolone acetonide-assisted internal limiting membrane peeling for chronic cystoid macular edema associated with branch retinal vein occlusion. Retina 2008;28:947–956
   PubMed Web of Science ®Google Scholar
• Uemura A, Yamamoto S, Sato E, et al. Vitrectomy alone versus vitrectomy with simultaneous intravitreal injection of triamcinolone for macular edema associated with branch retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2009;40:6–12
   PubMedGoogle Scholar
• Hirano Y, Sakurai E, Yoshida M, Ogura Y. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion. Ophthalmic Res 2007;39:207–212
   Google Scholar
• Udaondo P, Díaz-Llopis M, García-Delpech S, et al. Intravitreal plasmin without vitrectomy for macular edema secondary to branch retinal vein occlusion. Arch Ophthalmol 2011;129:283–287
   PubMedGoogle Scholar
• Tsujikawa A, Fujihara M, Iwawaki T, et al. Triamcinolone acetonide with vitrectomy for treatment of macular edema associated with branch retinal vein occlusion. Retina 2005;25:861–867
   Web of Science ®Google Scholar
• Wetzig PC. The treatment of acute branch vein occlusion by photocoagulation. Trans Am Ophthalmol Soc 1978;76:654–669
   Google Scholar
• Shilling JS, Jones CA. Retinal branch vein occlusion: A study of argon laser photocoagulation in the treatment of macular oedema. Br J Ophthalmol 1984;68:196–198
   Google Scholar
• Gutman FA, Zegarra H, Rauer A, Zakov N. Photocoagulation in retinal branch vein occlusion. Trans Am Ophthalmol Soc 1980;78:156–166
   Google Scholar
• Jalkh AE, Avila MP, Zakka KA, et al. Chronic macular edema in retinal branch vein occlusion: Role of laser photocoagulation. Ann Ophthalmol 1984;16:526–529
   Google Scholar
• The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984;98:271–282
   PubMed Web of Science ®Google Scholar
• Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Arch Ophthalmol 1986;104:34–41
   PubMedGoogle Scholar
• Finkelstein D. Argon laser photocoagulation for macular edema in branch vein occlusion. Ophthalmology 1986;93:975–977
   Google Scholar
• Gaudric A, Giorgi F, Sterkers M, et al. Photocoagulation with the argon laser in cystoid macular edema in retinal venous occlusions: Apropos of 68 cases. J Fr Ophtalmol 1988;11:319–326
   Google Scholar
• Rehák J, Vymazal M. Treatment of branch retinal vein occlusion with argon laser photocoagulation. Acta Univ Palacki Olomuc Fac Med 1989;123:231–236
   PubMedGoogle Scholar
• Bouzikas SP, Tsirou M, Economidis I, Pollalis SP. Argon-green laser photocoagulation in the treatment of cystoid macular edema secondary to branch vein occlusion. J Fr Ophtalmol 1989;12:909–914
   Google Scholar
• Battaglia Parodi M, Saviano S, Ravalico G. Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 1999;237:1024–1027
   Google Scholar
• Battaglia Parodi M, Saviano S, Bergamini L, Ravalico G. Grid laser treatment of macular edema in macular branch retinal vein occlusion. Doc Ophthalmol 1999;97:427–431
   Google Scholar
• Scott IU, VanVeldhuisen PC, Oden NL, et al. SCORE Study report 1: Baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology 2009;116:504–512
   PubMed Web of Science ®Google Scholar
• Scott IU, Ip MS, VanVeldhuisen PC, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: The Standard Care versus Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol 2009;127:1115–1128
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Rubenstein L, Podhajsky P. Argon laser scatter photocoagulation in treatment of branch retinal vein occlusion: A prospective clinical trial. Ophthalmologica 1993;206:1–14
   Google Scholar
• Pitcher JD 3rd, Liu T, Prasad PS, et al. Short-duration focal pattern grid photocoagulation for macular edema secondary to branch retinal vein occlusion. Semin Ophthalmol 2012;27:69–72
   Web of Science ®Google Scholar
• Soheilian M, Karimi S, Ramezani A, Peyman GA. Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies. Retina 2010;30:509–515
   PubMed Web of Science ®Google Scholar
• Coscas G, Loewenstein A, Augustin A, et al. Management of retinal vein occlusion–consensus document. Ophthalmologica 2011;226:4–28
   PubMed Web of Science ®Google Scholar
• Lattanzio R, Torres Gimeno A, Battaglia Parodi M, et al. Retinal vein occlusion: Current treatment. Ophthalmologica 2011;225:135–143
   Web of Science ®Google Scholar
• Degenring RF, Kamppeter B, Kreissig I, Jonas JB. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion. Acta Ophthalmol Scand 2003;81:548–550
   PubMedGoogle Scholar
• Wakabayashi T, Okada AA, Morimura Y, et al. Trans-tenon retrobulbar triamcinolone infusion for chronic macular edema in central and branch retinal vein occlusion. Retina 2004;24:964–967
   PubMed Web of Science ®Google Scholar
• Chen SD, Lochhead J, Patel CK, Frith P. Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion. Br J Ophthalmol 2004;88:154–155
   PubMed Web of Science ®Google Scholar
• Yepremyan M, Wertz FD, Tivnan T, et al. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging 2005;36:30–36
   PubMedGoogle Scholar
• Chen SD, Lochhead J, Satchi K, et al. Bilateral retinal venous occlusion and unilateral cystoid macular edema in Churg-Strauss syndrome treated with intravitreal triamcinolone. Retina 2005;25:655–657
   Google Scholar
• Salinas-Alamán A, García-Layana A, Sádaba-Echarri LM, Belzunce-Manterola A. Branch retinal vein occlusion treated by intravitreal triamcinolone. Arch Soc Esp Oftalmol 2005;80:463–465
   Google Scholar
• Lee H, Shah GK. Intravitreal triamcinolone as primary treatment of cystoid macular edema secondary to branch retinal vein occlusion. Retina 2005;25:551–555
   PubMed Web of Science ®Google Scholar
• Hayashi K, Hayashi H. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2005;139:972–982
   PubMed Web of Science ®Google Scholar
• Ozkiris A, Evereklioglu C, Erkiliç K, Ilhan O. The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion. Eur J Ophthalmol 2005;15:96–101
   PubMedGoogle Scholar
• Jonas JB, Akkoyun I, Kamppeter B, et al. Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye 2005;19:65–71
   PubMed Web of Science ®Google Scholar
• Tsujikawa A, Fujihara M, Iwawaki T, et al. Triamcinolone acetonide with vitrectomy for treatment of macular edema associated with branch retinal vein occlusion. Retina 2005;25:861–867
   Web of Science ®Google Scholar
• Karacorlu M, Ozdemir H, Karacorlu SA. Resolution of serous macular detachment after intravitreal triamcinolone acetonide treatment of patients with branch retinal vein occlusion. Retina 2005;25:856–860
   PubMed Web of Science ®Google Scholar
• Cekiç O, Chang S, Tseng JJ, et al. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina 2005;25:851–855
   PubMed Web of Science ®Google Scholar
• Avitabile T, Longo A, Reibaldi A. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol 2005;140:695–702
   PubMed Web of Science ®Google Scholar
• Krepler K, Ergun E, Sacu S, et al. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: A pilot study. Acta Ophthalmol Scand 2005;83:600–604
   Google Scholar
• Tewari HK, Sony P, Chawla R, et al. Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders. Eur J Ophthalmol 2005;15:619–626
   Google Scholar
• Ozkiris A, Evereklioglu C, Erkilic K, Dogan H. Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion. Eye 2006;20:13–17
   PubMed Web of Science ®Google Scholar
• Cheng KC, Wu WC. Intravitreal triamcinolone acetonide for patients with macular edema due to branch retinal vein occlusion. Kaohsiung J Med Sci 2006;22:321–330
   PubMedGoogle Scholar
• Oh JY, Seo JH, Ahn JK, et al. Early versus late intravitreal triamcinolone acetonide for macular edema associated with branch retinal vein occlusion. Korean J Ophthalmol 2007;21:18–20
   PubMedGoogle Scholar
• Cakir M, Dogan M, Bayraktar Z, et al. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation. Retina 2008;28:465–472
   PubMed Web of Science ®Google Scholar
• Patel PJ, Zaheer I, Karia N. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion. Eye 2008;22:60–64
   PubMed Web of Science ®Google Scholar
• Ozdek S, Deren YT, Gurelik G, Hasanreisoglu B. Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion. Ophthalmic Res 2008;40:26–31
   PubMed Web of Science ®Google Scholar
• Ramezani A, Entezari M, Moradian S, et al. Intravitreal triamcinolone for acute branch retinal vein occlusion: a randomized clinical trial. J Ophthalmic Vis Res 2011;6:101–108
   Google Scholar
• Seymenoğlu G, Kayıkçıoğlu O, Sahin BÖ. Resolution of vitreomacular traction following intravitreal triamcinolone acetonide injection in an eye with branch retinal vein occlusion. Clin Ophthalmol 2012;6:1239–1243
   Google Scholar
• Noma H, Funatsu H, Mimura T, Shimada K. Functional-morphological changes after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion. J Ocul Pharmacol Ther 2012;28:231–236
   Google Scholar
• Kawaji T, Hirata A, Awai N, et al. Trans-tenon retrobulbar triamcinolone injection for macular edema associated with branch retinal vein occlusion remaining after vitrectomy. Am J Ophthalmol 2005;140:540–542
   PubMed Web of Science ®Google Scholar
• Parodi MB, Iacono P, Ravalico G. Intravitreal triamcinolone acetonide combined with subthreshold grid laser treatment for macular oedema in branch retinal vein occlusion: A pilot study. Br J Ophthalmol 2008;92:1046–1050
   PubMed Web of Science ®Google Scholar
• Riese J, Loukopoulos V, Meier C, et al. Combined intravitreal triamcinolone injection and laser photocoagulation in eyes with persistent macular edema after branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2008;246:1671–1676
   PubMed Web of Science ®Google Scholar
• Hayashi A, Yunoki T, Miyakoshi A, et al. Intravitreal injection of bevacizumab combined with macular grid laser photocoagulation for macular edema in branch retinal vein occlusion. Jpn J Ophthalmol 2011;55:625–631
   Google Scholar
• Ehrlich R, Ciulla TA, Moss AM, Harris A. Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up. Graefes Arch Clin Exp Ophthalmol 2010;248:375–380
   Google Scholar
• Robinson MR, Whitcup SM. Pharmacologic and clinical profile of dexamethasone intravitreal implant. Expert Rev Clin Pharmacol 2012;5:629–647
   PubMed Web of Science ®Google Scholar
• Haller JA, Bandello F, Belfort R Jr, et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117:1134–1146
   PubMed Web of Science ®Google Scholar
• Haller JA, Bandello F, Belfort R Jr, et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 2011;118:2453–2460
   PubMed Web of Science ®Google Scholar
• Coscas G, Coscas F, Zucchiatti I, et al. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®. Eur J Ophthalmol 2011;21:631–636
   Google Scholar
• Moisseiev E, Goldstein M, Waisbourd M, et al. Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion. Eye 2013;27:65–71
   PubMed Web of Science ®Google Scholar
• Yeh WS, Haller JA, Lanzetta P, et al. Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. Ophthalmology 2012;119:1190–1198
   PubMed Web of Science ®Google Scholar
• Mayer WJ, Remy M, Wolf A, et al. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema. Ophthalmologica 2012;228:110–116
   PubMed Web of Science ®Google Scholar
• Singer MA, Bell DJ, Woods P, et al. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion. Retina 2012;32:1289–1294
   PubMed Web of Science ®Google Scholar
• Gragoudas ES, Adamis AP, Cunningham ET Jr, et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805–2816
   PubMed Web of Science ®Google Scholar
• Sultan MB, Zhou D, Loftus J, et al. A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema. Ophthalmology 2011;118:1107–1118
   PubMed Web of Science ®Google Scholar
• González VH, Giuliari GP, Banda RM, Guel DA. Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy. Br J Ophthalmol 2009;93:1474–1478
   PubMed Web of Science ®Google Scholar
• Adamis AP, Altaweel M, Bressler NM, et al. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology 2006;113:23–28
   PubMed Web of Science ®Google Scholar
• Wroblewski JJ, Wells JA, Adamis AP, et al. Pegaptanib sodium for macular edema secondary to central retinal vein occlusion. Arch Ophthalmol 2009;127:374–380
   PubMed Web of Science ®Google Scholar
• Wroblewski JJ, Wells JA 3rd, Gonzales CR. Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion. Am J Ophthalmol 2010;149:147–154
   PubMed Web of Science ®Google Scholar
• Wong I, Koo S, Chan C. Pegaptanib for branch retinal vein occlusion. Am J Ophthalmol 2010;150:129
   Google Scholar
• Gallego-Pinazo R, Francés E, Gómez MJ, et al. Initial and unique treatment of macular edema due to branch retinal vein occlusion with antiangiogenic agents: A comparative pilot study. Arch Soc Esp Oftalmol 2009;84:229–230
   Google Scholar
• Udaondo P, Garcia-Delpech S, Salom D, et al. Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion. Clin Ophthalmol 2011;5:941–944
   PubMedGoogle Scholar
• Wu L, Arevalo JF, Berrocal MH, et al. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: Results of the Pan American Collaborative Retina Study Group at 24 months. Retina 2009;29:1396–1403
   PubMed Web of Science ®Google Scholar
• Ahmadieh H, Moradian S, Malihi M. Rapid regression of extensive retinovitreal neovascularization secondary to branch retinal vein occlusion after a single intravitreal injection of bevacizumab. Int Ophthalmol 2005;26:191–193
   Google Scholar
• Jaissle GB, Ziemssen F, Petermeier K, et al. Bevacizumab for treatment of macular edema secondary to retinal vein occlusion. Ophthalmologe 2006;103:471–475
   PubMed Web of Science ®Google Scholar
• Spandau U, Wickenhäuser A, Rensch F, Jonas J. Intravitreal bevacizumab for branch retinal vein occlusion. Acta Ophthalmol Scand 2007;85:118–119
   PubMedGoogle Scholar
• Pai SA, Shetty R, Vijayan PB, et al. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol 2007;143:601–606
   PubMed Web of Science ®Google Scholar
• Schaal KB, Höh AE, Scheuerle A, et al. Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Ophthalmologe 2007;104:285–289
   Google Scholar
• Stahl A, Agostini H, Hansen LL, Feltgen N. Bevacizumab in retinal vein occlusion: Results of a prospective case series. Graefes Arch Clin Exp Ophthalmol 2007;245:1429–1436
   PubMed Web of Science ®Google Scholar
• Rabena MD, Pieramici DJ, Castellarin AA, et al. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007;27:419–425
   PubMed Web of Science ®Google Scholar
• Kreutzer TC, Alge CS, Wolf AH, et al. Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 2008;92:351–355
   PubMed Web of Science ®Google Scholar
• Kriechbaum K, Michels S, Prager F, et al. Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: A prospective study. Br J Ophthalmol 2008;92:518–522
   PubMed Web of Science ®Google Scholar
• Gündüz K, Bakri SJ. Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion. Eye 2008;22:1168–1171
   Google Scholar
• Wu L, Arevalo JF, Roca JA, et al. Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: Results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up. Retina 2008;28:212–219
   PubMed Web of Science ®Google Scholar
• Chalam KV, Keshavamurthy R, Brar VS. Spectral domain OCT documented resolution of recalcitrant macular edema after intravitreal bevacizumab in branch retinal vein occlusion. Eur J Ophthalmol 2008;18:831–833
   Google Scholar
• Abegg M, Tappeiner C, Wolf-Schnurrbusch U, et al. Treatment of branch retinal vein occlusion induced macular edema with bevacizumab. BMC Ophthalmol 2008;8:18
   Web of Science ®Google Scholar
• Chung EJ, Hong YT, Lee SC, et al. Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2008;246:1241–1247
   PubMed Web of Science ®Google Scholar
• Rensch F, Jonas JB, Spandau UH. Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion. Ophthalmologica 2009;223:124–127
   Google Scholar
• Jaissle GB, Leitritz M, Gelisken F, et al. One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2009;247:27–33
   PubMed Web of Science ®Google Scholar
• Prager F, Michels S, Kriechbaum K, et al. Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol 2009;93:452–456
   PubMed Web of Science ®Google Scholar
• Ahmadi AA, Chuo JY, Banashkevich A, et al. The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion. Can J Ophthalmol 2009;44:154–159
   PubMed Web of Science ®Google Scholar
• Gregori NZ, Rattan GH, Rosenfeld PJ, et al. Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion. Retina 2009;29:913–925
   PubMed Web of Science ®Google Scholar
• Yamauchi Y, Mori F, Masahara H, et al. Use of intravitreal bevacizumab for macular edema in branch retinal vein occlusion. Nihon Ganka Gakkai Zasshi 2009;113:672–674
   Google Scholar
• Hoeh AE, Ach T, Schaal KB, et al. Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2009;247:1635–1641
   PubMed Web of Science ®Google Scholar
• Gutiérrez JC, Barquet LA, Caminal JM, et al. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion. Clin Ophthalmol 2008;2:787–791
   Google Scholar
• Kondo M, Kondo N, Ito Y, et al. Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion: Results after 12 months and multiple regression analysis. Retina 2009;29:1242–1248
   PubMed Web of Science ®Google Scholar
• Figueroa MS, Contreras I, Noval S, Arruabarrena C. Results of bevacizumab as the primary treatment for retinal vein occlusions. Br J Ophthalmol 2010;94:1052–1056
   PubMed Web of Science ®Google Scholar
• Hara S, Sakuraba T, Kataoka H, et al. Effect of repeated intravitreal bevacizumab injections for secondary macular edema of branch retinal vein occlusion. Nihon Ganka Gakkai Zasshi 2010;114:1013–1018
   Google Scholar
• Lim JW. Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion. Ophthalmologica 2011;225:150–154
   PubMed Web of Science ®Google Scholar
• Ehlers JP, Decroos FC, Fekrat S. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion. Retina 2011;31:1856–1862
   PubMed Web of Science ®Google Scholar
• Demir M, Oba E, Gulkilik G, et al. Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results. Clin Ophthalmol 2011;5:745–749
   Google Scholar
• Yunoki T, Miyakoshi A, Nakamura T, et al. Treatment of macular edema due to branch retinal vein occlusion with single or multiple intravitreal injections of bevacizumab. Jpn J Ophthalmol 2012;56:159–164
   Google Scholar
• Thapa R, Maharjan N, Paudyal G. Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results. Clin Ophthalmol 2012;6:1057–1062
   Google Scholar
• Preti RC, Ramirez LM, Pimentel SL, et al. Single intravitreal bevacizumab injection effects on contrast sensitivity in macular edema from branch retinal vein occlusion. Arq Bras Oftalmol 2012;75:29–32
   Google Scholar
• Siegel RA, Dreznik A, Mimouni K, et al. Intravitreal bevacizumab treatment for macular edema due to branch retinal vein occlusion in a clinical setting. Curr Eye Res 2012;37:823–829
   Web of Science ®Google Scholar
• Kang HM, Chung EJ, Kim YM, Koh HJ. Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2013;251:501–508
   Web of Science ®Google Scholar
• Park S, Cho IH, Park TK, et al. Extrafoveal changes following intravitreal bevacizumab injections for macular edema secondary to branch retinal vein occlusion: An mfERG and OCT study. Doc Ophthalmol 2013;126:137--148
   Google Scholar
• Matsumoto Y, Freund KB, Peiretti E, et al. Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina 2007;27:426–431
   PubMed Web of Science ®Google Scholar
• Campa C, D'Angelo S, Incorvaia C. Comment of article by Matsumoto Y. Retina 2008;28:782
   Google Scholar
• Deka S, Kalita K, Singh SK. Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion. Oman J Ophthalmol 2009;2:94–95
   Google Scholar
• Yasuda S, Kondo M, Kachi S, et al. Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion. Retina 2011;31:1075–1082
   Google Scholar
• Hanada N, Iijima H, Sakurada Y, Imasawa M. Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab. Jpn J Ophthalmol 2012;56:165–174
   Google Scholar
• Hayashi A, Yunoki T, Miyakoshi A, et al. Intravitreal injection of bevacizumab combined with macular grid laser photocoagulation for macular edema in branch retinal vein occlusion. Jpn J Ophthalmol 2011;55:625–631
   Google Scholar
• Donati S, Barosi P, Bianchi M, et al. Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion. Eur J Ophthalmol 2012;22:607–614
   PubMed Web of Science ®Google Scholar
• Ogino K, Tsujikawa A, Murakami T, et al. Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion. Clin Ophthalmol 2011;5:1031–1036
   Google Scholar
• Salinas-Alamán A, Zarranz-Ventura J, Caire González-Jauregui JM, et al. Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion. Eur J Ophthalmol 2011;21:434–439
   Google Scholar
• Russo V, Barone A, Conte E, et al. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion. Retina 2009;29:511–515
   PubMed Web of Science ®Google Scholar
• Parveen S, Narayanan R, Sambhav K, Bhatia K. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion. Retina 2010;30:1324–1325; author reply 1325
   Google Scholar
• Leitritz MA, Gelisken F, Ziemssen F, et al. Grid laser photocoagulation for macular oedema due to branch retinal vein occlusion in the age of bevacizumab? Results of a prospective study with crossover design. Br J Ophthalmol 2013;97:215–219
   Google Scholar
• Kelkar AS, Sayyad MG, Kelkar JA, et al. Comparison of single injection of intravitreal triamcinolone versus single injection of intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusions with regard to changes in best corrected visual acuity and central macular thickness in the short term. Indian J Ophthalmol 2009;57:243–244
   Google Scholar
• Kim JY, Park SP. Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion. Korean J Ophthalmol 2009;23:259–265
   Google Scholar
• Hou J, Tao Y, Jiang YR, et al. Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: A matched study. Chin Med J 2009;122:2695–2699
   Web of Science ®Google Scholar
• Cheng KC, Wu WC, Chen KJ. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion. Eye 2009;23:2023–2033
   PubMedGoogle Scholar
• Chen CH, Chen YH, Wu PC, et al. Treatment of branch retinal vein occlusion induced macular edema in treatment-naïve cases with a single intravitreal triamcinolone or bevacizumab injection. Chang Gung Med J 2010;33:424–435
   Google Scholar
• Guthoff R, Meigen T, Hennemann K, Schrader W. Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in a pair-matched analysis. Ophthalmologica 2010;224:319–324
   PubMed Web of Science ®Google Scholar
• Byun YJ, Roh MI, Lee SC, Koh HJ. Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2010;248:963–971
   Google Scholar
• Cekiç O, Cakır M, Yazıcı AT, et al. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. Curr Eye Res 2010;35:925–929
   PubMed Web of Science ®Google Scholar
• Higashiyama T, Sawada O, Kakinoki M, et al. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion. Acta Ophthalmol 2013;91:318--324
   Google Scholar
• Ramezani A, Esfandiari H, Entezari M, et al. Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent-onset branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2012;250:1149–1160
   PubMedGoogle Scholar
• Campochiaro PA, Hafiz G, Shah SM, et al. Ranibizumab for macular edema due to retinal vein occlusions: Implication of VEGF as a critical stimulator. Mol Ther 2008;16:791–799
   PubMed Web of Science ®Google Scholar
• Gallego-Pinazo R, Francés E, Gómez MJ, et al. Initial and unique treatment of macular edema due to branch retinal vein occlusion with antiangiogenic agents: A comparative pilot study. Arch Soc Esp Oftalmol 2009;84:229–230
   Google Scholar
• Campochiaro PA, Hafiz G, Channa R, et al. Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: Two-year outcomes. Ophthalmology 2010;117:2387–2394
   PubMed Web of Science ®Google Scholar
• Campochiaro PA, Heier JS, Feiner L, et al. Ranibizumab for macular edema following branch retinal vein occlusion: Six-month primary end point results of a phase III study. Ophthalmology 2010;117:1102–1112
   PubMed Web of Science ®Google Scholar
• Rouvas A, Petrou P, Ntouraki A, et al. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: Nine-month results of a prospective study. Retina 2010;30:893–902
   Google Scholar
• Pece A, Isola V, Piermarocchi S, Calori G. Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion: 1-year follow-up. Br J Ophthalmol 2011;95:56–68
   PubMed Web of Science ®Google Scholar
• Brown DM, Campochiaro PA, Bhisitkul RB, et al. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology 2011;118:1594–1602
   PubMed Web of Science ®Google Scholar
• Azad R, Vivek K, Sharma Y, et al. Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion. Indian J Ophthalmol 2012;60:263–266
   Google Scholar
• Puche N, Glacet A, Mimoun G, et al. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes. Acta Ophthalmol 2012;90:357–361
   PubMed Web of Science ®Google Scholar
• Kim M, Yu SY, Kim ES, et al. Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion. Ophthalmologica 2012;227:132–138
   Google Scholar
• Heier JS, Campochiaro PA, Yau L, et al. Ranibizumab for macular edema due to retinal vein occlusions: Long-term follow-up in the HORIZON trial. Ophthalmology 2012;119:802–809
   PubMed Web of Science ®Google Scholar
• Varma R, Bressler NM, Suñer I, et al. Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: Results from the BRAVO and CRUISE trials. Ophthalmology 2012;119:2108–2118
   PubMed Web of Science ®Google Scholar
• Karagiannis DA, Karampelas MD, Soumplis VM, et al. Recurrence of macular edema in retinal vein occlusions after treatment with intravitreal ranibizumab (Lucentis). Can J Ophthalmol 2011;46:486–490
   Google Scholar